Whole exome sequencing reveals concomitant mutations of multiple FA genes in individual Fanconi anemia patients

Lixian Chang, Weiping Yuan, Huimin Zeng, Quanquan Zhou, Wei Wei, Jianfeng Zhou, Miaomiao Li, Xiaomin Wang, Mingjiang Xu, Fengchun Yang, Yungui Yang, Tao Cheng, Xiaofan Zhu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Fanconi anemia (FA) is a rare inherited genetic syndrome with highly variable clinical manifestations. Fifteen genetic subtypes of FA have been identified. Traditional complementation tests for grouping studies have been used generally in FA patients and in stepwise methods to identify the FA type, which can result in incomplete genetic information from FA patients. Methods. We diagnosed five pediatric patients with FA based on clinical manifestations, and we performed exome sequencing of peripheral blood specimens from these patients and their family members. The related sequencing data were then analyzed by bioinformatics, and the FANC gene mutations identified by exome sequencing were confirmed by PCR re-sequencing. Results: Homozygous and compound heterozygous mutations of FANC genes were identified in all of the patients. The FA subtypes of the patients included FANCA, FANCM and FANCD2. Interestingly, four FA patients harbored multiple mutations in at least two FA genes, and some of these mutations have not been previously reported. These patients' clinical manifestations were vastly different from each other, as were their treatment responses to androstanazol and prednisone. This finding suggests that heterozygous mutation(s) in FA genes could also have diverse biological and/or pathophysiological effects on FA patients or FA gene carriers. Interestingly, we were not able to identify de novo mutations in the genes implicated in DNA repair pathways when the sequencing data of patients were compared with those of their parents. Conclusions: Our results indicate that Chinese FA patients and carriers might have higher and more complex mutation rates in FANC genes than have been conventionally recognized. Testing of the fifteen FANC genes in FA patients and their family members should be a regular clinical practice to determine the optimal care for the individual patient, to counsel the family and to obtain a better understanding of FA pathophysiology.

Original languageEnglish
Article number24
JournalBMC Medical Genomics
Volume7
Issue number1
DOIs
StatePublished - May 15 2014

Fingerprint

Exome
Fanconi Anemia
Mutation
Genes
Stanozolol
Genetic Complementation Test
Mutation Rate
Prednisone

Keywords

  • Concomitant mutation
  • DNA repair
  • Exome sequencing
  • Fanconi anemia

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Whole exome sequencing reveals concomitant mutations of multiple FA genes in individual Fanconi anemia patients. / Chang, Lixian; Yuan, Weiping; Zeng, Huimin; Zhou, Quanquan; Wei, Wei; Zhou, Jianfeng; Li, Miaomiao; Wang, Xiaomin; Xu, Mingjiang; Yang, Fengchun; Yang, Yungui; Cheng, Tao; Zhu, Xiaofan.

In: BMC Medical Genomics, Vol. 7, No. 1, 24, 15.05.2014.

Research output: Contribution to journalArticle

Chang, L, Yuan, W, Zeng, H, Zhou, Q, Wei, W, Zhou, J, Li, M, Wang, X, Xu, M, Yang, F, Yang, Y, Cheng, T & Zhu, X 2014, 'Whole exome sequencing reveals concomitant mutations of multiple FA genes in individual Fanconi anemia patients', BMC Medical Genomics, vol. 7, no. 1, 24. https://doi.org/10.1186/1755-8794-7-24
Chang, Lixian ; Yuan, Weiping ; Zeng, Huimin ; Zhou, Quanquan ; Wei, Wei ; Zhou, Jianfeng ; Li, Miaomiao ; Wang, Xiaomin ; Xu, Mingjiang ; Yang, Fengchun ; Yang, Yungui ; Cheng, Tao ; Zhu, Xiaofan. / Whole exome sequencing reveals concomitant mutations of multiple FA genes in individual Fanconi anemia patients. In: BMC Medical Genomics. 2014 ; Vol. 7, No. 1.
@article{ec6a470a53854c439a6eb3c57b783d7a,
title = "Whole exome sequencing reveals concomitant mutations of multiple FA genes in individual Fanconi anemia patients",
abstract = "Background: Fanconi anemia (FA) is a rare inherited genetic syndrome with highly variable clinical manifestations. Fifteen genetic subtypes of FA have been identified. Traditional complementation tests for grouping studies have been used generally in FA patients and in stepwise methods to identify the FA type, which can result in incomplete genetic information from FA patients. Methods. We diagnosed five pediatric patients with FA based on clinical manifestations, and we performed exome sequencing of peripheral blood specimens from these patients and their family members. The related sequencing data were then analyzed by bioinformatics, and the FANC gene mutations identified by exome sequencing were confirmed by PCR re-sequencing. Results: Homozygous and compound heterozygous mutations of FANC genes were identified in all of the patients. The FA subtypes of the patients included FANCA, FANCM and FANCD2. Interestingly, four FA patients harbored multiple mutations in at least two FA genes, and some of these mutations have not been previously reported. These patients' clinical manifestations were vastly different from each other, as were their treatment responses to androstanazol and prednisone. This finding suggests that heterozygous mutation(s) in FA genes could also have diverse biological and/or pathophysiological effects on FA patients or FA gene carriers. Interestingly, we were not able to identify de novo mutations in the genes implicated in DNA repair pathways when the sequencing data of patients were compared with those of their parents. Conclusions: Our results indicate that Chinese FA patients and carriers might have higher and more complex mutation rates in FANC genes than have been conventionally recognized. Testing of the fifteen FANC genes in FA patients and their family members should be a regular clinical practice to determine the optimal care for the individual patient, to counsel the family and to obtain a better understanding of FA pathophysiology.",
keywords = "Concomitant mutation, DNA repair, Exome sequencing, Fanconi anemia",
author = "Lixian Chang and Weiping Yuan and Huimin Zeng and Quanquan Zhou and Wei Wei and Jianfeng Zhou and Miaomiao Li and Xiaomin Wang and Mingjiang Xu and Fengchun Yang and Yungui Yang and Tao Cheng and Xiaofan Zhu",
year = "2014",
month = "5",
day = "15",
doi = "10.1186/1755-8794-7-24",
language = "English",
volume = "7",
journal = "BMC Medical Genomics",
issn = "1755-8794",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Whole exome sequencing reveals concomitant mutations of multiple FA genes in individual Fanconi anemia patients

AU - Chang, Lixian

AU - Yuan, Weiping

AU - Zeng, Huimin

AU - Zhou, Quanquan

AU - Wei, Wei

AU - Zhou, Jianfeng

AU - Li, Miaomiao

AU - Wang, Xiaomin

AU - Xu, Mingjiang

AU - Yang, Fengchun

AU - Yang, Yungui

AU - Cheng, Tao

AU - Zhu, Xiaofan

PY - 2014/5/15

Y1 - 2014/5/15

N2 - Background: Fanconi anemia (FA) is a rare inherited genetic syndrome with highly variable clinical manifestations. Fifteen genetic subtypes of FA have been identified. Traditional complementation tests for grouping studies have been used generally in FA patients and in stepwise methods to identify the FA type, which can result in incomplete genetic information from FA patients. Methods. We diagnosed five pediatric patients with FA based on clinical manifestations, and we performed exome sequencing of peripheral blood specimens from these patients and their family members. The related sequencing data were then analyzed by bioinformatics, and the FANC gene mutations identified by exome sequencing were confirmed by PCR re-sequencing. Results: Homozygous and compound heterozygous mutations of FANC genes were identified in all of the patients. The FA subtypes of the patients included FANCA, FANCM and FANCD2. Interestingly, four FA patients harbored multiple mutations in at least two FA genes, and some of these mutations have not been previously reported. These patients' clinical manifestations were vastly different from each other, as were their treatment responses to androstanazol and prednisone. This finding suggests that heterozygous mutation(s) in FA genes could also have diverse biological and/or pathophysiological effects on FA patients or FA gene carriers. Interestingly, we were not able to identify de novo mutations in the genes implicated in DNA repair pathways when the sequencing data of patients were compared with those of their parents. Conclusions: Our results indicate that Chinese FA patients and carriers might have higher and more complex mutation rates in FANC genes than have been conventionally recognized. Testing of the fifteen FANC genes in FA patients and their family members should be a regular clinical practice to determine the optimal care for the individual patient, to counsel the family and to obtain a better understanding of FA pathophysiology.

AB - Background: Fanconi anemia (FA) is a rare inherited genetic syndrome with highly variable clinical manifestations. Fifteen genetic subtypes of FA have been identified. Traditional complementation tests for grouping studies have been used generally in FA patients and in stepwise methods to identify the FA type, which can result in incomplete genetic information from FA patients. Methods. We diagnosed five pediatric patients with FA based on clinical manifestations, and we performed exome sequencing of peripheral blood specimens from these patients and their family members. The related sequencing data were then analyzed by bioinformatics, and the FANC gene mutations identified by exome sequencing were confirmed by PCR re-sequencing. Results: Homozygous and compound heterozygous mutations of FANC genes were identified in all of the patients. The FA subtypes of the patients included FANCA, FANCM and FANCD2. Interestingly, four FA patients harbored multiple mutations in at least two FA genes, and some of these mutations have not been previously reported. These patients' clinical manifestations were vastly different from each other, as were their treatment responses to androstanazol and prednisone. This finding suggests that heterozygous mutation(s) in FA genes could also have diverse biological and/or pathophysiological effects on FA patients or FA gene carriers. Interestingly, we were not able to identify de novo mutations in the genes implicated in DNA repair pathways when the sequencing data of patients were compared with those of their parents. Conclusions: Our results indicate that Chinese FA patients and carriers might have higher and more complex mutation rates in FANC genes than have been conventionally recognized. Testing of the fifteen FANC genes in FA patients and their family members should be a regular clinical practice to determine the optimal care for the individual patient, to counsel the family and to obtain a better understanding of FA pathophysiology.

KW - Concomitant mutation

KW - DNA repair

KW - Exome sequencing

KW - Fanconi anemia

UR - http://www.scopus.com/inward/record.url?scp=84902072548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902072548&partnerID=8YFLogxK

U2 - 10.1186/1755-8794-7-24

DO - 10.1186/1755-8794-7-24

M3 - Article

C2 - 24885126

AN - SCOPUS:84902072548

VL - 7

JO - BMC Medical Genomics

JF - BMC Medical Genomics

SN - 1755-8794

IS - 1

M1 - 24

ER -